Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115328) titled 'Clinical study on targeted extracellular matrix denatured collagen molecular probe' on Dec. 24, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Affiliated Hospital of Guilin Medical University
Condition:
Malignant tumor
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-01-01
Target Sample Size: 68Ga-CHP-04:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=301538
Published by HT Digital Content Services with permission from Health Daily Digest....